The future of long-lasting relief: Lasting Effect Buccal Extended-Release Delivery System

Lasting Effect Consumer Pharma

We are a consumer driven, pharma company, devoted to research and development of beneficial products based on our novel Mucoadhasive Buccal Extended Release Technology

our supporters

Buccal Transmucosal delivery Technology

Delivering drugs topically / systemically through the oral mucosa
Many advantages compered to Oral Trans digestive delivery.
Facilitates population with Dysphagia / salivation problems
Solving user compliance challenge of buccal delivery

dry mouth (xerostomia) and continuous oral health

Mucoadhasive buccal extended release saliva stimulating tablet for dry mouth (xerostomia) treatment and continuous oral health. 2 hours intended use.

Gingivitis treatment buccal extended release tablet

Anti-inflammatory and antibacterial mucoadhasive buccal extended release tablet with CBD for Gingivitis treatmant. 4 hours intended use

PARKINSON LATE MOTOR COMPLICATIONS

Mucoadhasive buccal extended-release tablet loaded with antiparkinsonian API for continuous dopamine secretion. 6 hours intended use

Investors Opportunity

Existing markets
Major improvement of existing treatments
Product Market Fit
Experienced team
Novelty and patentability
Future pipeline
High feasibility for success